Results for aprepitanta translation from Slovenian to English

farmakokinetika aprepitanta ni linearna.
aprepitant displays non-linear pharmacokinetics.

ena kapsula vsebuje 165 mg aprepitanta.
each capsule contains 165 mg of aprepitant.

ena trda kapsula vsebuje 125 mg aprepitanta.
each hard capsule contains 125 mg of aprepitant.

vpliv drugih zdravil na farmakokinetiko aprepitanta
effect of other medicinal products on the pharmacokinetics of aprepitant

ena 125 mg kapsula vsebuje 125 mg aprepitanta.
each 125 mg capsule contains 125 mg of aprepitant.

presnova aprepitanta poteka večinoma z oksidacijo na
in humans, fosaprepitant administered intravenously was rapidly converted to aprepitant within 30 minutes following the end of infusion.

ena 125 mg trda kapsula vsebuje 125 mg aprepitanta.
each 125 mg hard capsule contains 125 mg of aprepitant.

učinek aprepitanta na farmakokinetiko drugih zdravilnih učinkovin
effect aprepitant on the pharmacokinetics of other active substances

v humani plazmi so identificirali 12 presnovkov aprepitanta.
twelve metabolites of aprepitant have been identified in human plasma.

učinkovitost aprepitanta se je očitno ohranjala v vseh ciklusih.
the efficacy of the aprepitant regimen was apparently maintained during all cycles.

po rekonstituciji 1 ml peroralne suspenzije vsebuje 25 mg aprepitanta.
after reconstitution, 1 ml of oral suspension contains 25 mg of aprepitant.

varnostne značilnosti aprepitanta so ocenili pri približno 6.500 odraslih.
the safety profile of aprepitant was evaluated in approximately 6,500 adults.

varnostni profil aprepitanta je bil ovrednoten pri približno 6.500 osebah.
the safety profile of aprepitant was evaluated in approximately 6,500 individuals.

kancerogeni potencial je bil pri glodavcih ovrednoten le pri peroralnem dajanju aprepitanta.
carcinogenic potential in rodents was only investigated with orally administered aprepitant.

rifampicin je zmanjšal povprečni končni razpolovni čas peroralnega aprepitanta za 68 %.
rifampicin decreased the mean terminal half-life of oral aprepitant by 68 %.

fosaprepitant, predzdravilo aprepitanta, se po intravenski aplikaciji hitro pretvori v aprepitant.
fosaprepitant, a prodrug of aprepitant, when administered intravenously is rapidly converted to aprepitant.

zdravilna učinkovina v zdravilu ivemend, fosaprepitant, je „predzdravilo“ aprepitanta.
the active substance in ivemend, fosaprepitant, is a ‘prodrug’ of aprepitant.